Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics

PartnershipPositive

AI Analysis

Summary

Rznomics Inc., a South Korean biopharmaceutical company specializing in RNA-based gene therapies, announced it is joining Lilly Gateway Labs in San Diego, California to accelerate development of its RNA therapeutics platform.

Importance:5/10

Sentiment:

0.60

partnershipRNA therapeuticsgene therapycollaboration

Related Companies

$LLY

Read the original article

Published by PR Newswire Biotech on August 24, 2026 1:54 AM

Read Original